FDA OKs Baxalta's drug for von Willebrand bleeding disorder
U.S. regulators on Tuesday approved the first genetically engineered treatment for the most common inherited bleeding disorder, von Willebrand disease.
Dec 8, 2015
Archive: 08/12/2015
Health care for Syrian refugees: A guide for Canadian physicians
What unique health needs will Syrian refugees face, and how can Canadian physicians best provide health care to them and their families? A practice article posted online today in CMAJ (Canadian Medical Association Journal) ...
Dec 8, 2015
One-two punch of palbociclib and paclitaxel shows promise against advanced breast cancer
Combining the new breast cancer drug palbociclib with paclitaxel (Taxol) shrank tumors in nearly half of patient with estrogen-receptor (ER) positive breast cancer, according to new research from the Perelman School of Medicine ...
Dec 8, 2015
Aspirin use does not improve outcomes for cancer patients, but may lower breast density
Whether aspirin may help prevent or reduce the risk of breast cancer remains a hotly debated research question. While past studies have indicated a potential benefit, most recently in hormone receptor-positive breast cancers, ...
Dec 8, 2015
